Advertisement
Elanco Animal Health Closes Sale Of Aqua Business To Merck Animal Health
(RTTNews) - Elanco Animal Health, Inc. (ELAN) announced Tuesday it has completed the divestiture of its aqua business to Merck Animal Health (MRK) for approximately $1.3 billion in cash, with approximately $1.05 billion to $1.1 billion in net proceeds available for debt paydown in the third quarter of 2024.
The successful completion of this transaction enables the company to pay down term loan debt on a pro-rata basis per the terms of the company's credit agreements.
Combined with the expected $280 million to $320 million of cash generated from the base business, the company expects to pay down approximately $1.3 billion to $1.4 billion of debt in 2024.
read more
Elanco Animal Health Boosts FY23 Adj. EPS, Revenue Outlook As Q3 Results Top Estimates
Elanco Animal Health Inc. (ELAN) reported Tuesday a net loss for the third quarter of $1.10 billion or $2.22 per share, sharply wider than $65.0 million or $0.13 per share in the prior-year quarter.
RTTNews
|
661天前
Elanco's Canine Parvovirus Treatment Gets USDA License
Elanco Animal Health Inc. announced that the U.S. Department of Agriculture or USDA has issued a conditional license for its Canine Parvovirus Monoclonal Antibody. The company expects to begin shipping Canine Parvovirus Monoclonal Antibody in the coming weeks, pending individual state approvals. The targeted single-dose monoclonal antibody is the first and only approved targeted therapeutic...
RTTNews
|
849天前
FDA Approves First Drug For Anemia In Cats With CKD
The U.S. Food and Drug Administration conditionally approved Elanco US Inc.'s Varenzin-CA1 (molidustat oral suspension) for treating anemia in cats with chronic kidney disease or CKD. It is the first drug for the control of nonregenerative anemia associated with CKD in cats. Varenzin-CA1 works by helping to increase production of erythropoietin in the kidney, which in turn stimulates the bone mar
RTTNews
|
850天前
European Shares Drift Lower Ahead Of US Inflation Reading
European stocks traded lower on Friday as investors waited for key U.S. inflation data due later in the day that could provide additional clues on a potential Federal Reserve rate cut in September.
RTTNews
|
48分鐘前
Antipodean Currencies Rise As Traders Await U.S. PCE Inflation Data
The antipodean currencies such as the Australia and the New Zealand dollars strengthened against their major currencies in the Asian session on Friday, as traders await the July Personal Consumption Expenditures (PCE) price index due later in the day.
RTTNews
|
49分鐘前
Asian Shares Mixed Ahead Of US PCE Inflation Data
Asian stocks ended mixed on Friday as caution prevailed ahead of a key U.S. inflation report due later in the day that might show core personal consumption expenditures prices rose 2.9 percent in July, the fastest pace in five months.
RTTNews
|
1小時4分鐘前
NZ Dollar Advances Against Majors
The New Zealand dollar strengthened against other major currencies in the Asian session on Friday.
RTTNews
|
2小時16分鐘前
Australian Dollar Rises Against Majors
The Australian dollar strengthened against other major currencies in the Asian session on Friday.
RTTNews
|
2小時22分鐘前
